Breast cancer in European Union: an update of screening programmes as of March 2014 (review)

Abstract

Breast cancer, a major cause of female morbidity and mortality, is a global health problem; 2008 data show an incidence of ~450,000 new cases and 140,000 deaths (mean incidence rate 70.7 and mortality rate 16.7, world age-standardized rate per 100,000 women) in European Union Member States. Incidence rates in Western Europe are among the highest in the world. We review the situation of BC screening programmes in European Union. Up to date information on active BC screening programmes was obtained by reviewing the literature and searching national health ministries and cancer service websites. Although BC screening programmes are in place in nearly all European Union countries there are still considerable differences in target population coverage and age and in the techniques deployed. Screening is a mainstay of early BC detection whose main weakness is the rate of participation of the target population. National policies and healthcare planning should aim at maximizing participation in controlled organized screening programmes by identifying and lowering any barriers to adhesion, also with a view to reducing healthcare costs.

Figure 1

Breast cancer incidence and mortality in the European Union (EU28). ASR-W, world age-standardized rates per 100,000.

Figure 2

Distribution of breast cancer screening programmes in EU28 and coverage rates. Participation data are divided into five classes from 0 to 100%. Participation rates are those reported in Table II. Member states for which attendance data were not available are indicated with NA.